vTv Therapeutics Inc.
VTVTDrugs in Pipeline
8
Phase 3 Programs
1
Upcoming Catalysts
2
Next Catalyst
Aug 11, 2026
7dMarket Overview
Stock performance and key metrics
2 upcoming, 0 past
VTVT Earnings Report
EPS Est: $-0.93 | FQ end 2026-06
1 more catalyst beyond 14 days
Start a 48-hour free trial to see all upcoming catalysts
How VTVT's past catalysts played out
Cadisegliatin 800 mg QD
Diabetes Mellitus, Type 1
TTP399 400 mg
Diabetes Mellitus, Type 2
GK1-399 (formerly TTP399)
Type 2 Diabetes Mellitus
TTP889
Venous Thromboembolism
TTP399
Diabetes Mellitus, Type 1
TTP273
Type 2 Diabetes Mellitus
TTP054
Type 2 Diabetes Mellitus
TTP435
Obesity
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Cadisegliatin 800 mg QD | Phase 3 | Diabetes Mellitus, Type 1 | - | - |
TTP399 400 mg | Phase 2 | Diabetes Mellitus, Type 2 | - | - |
GK1-399 (formerly TTP399) | Phase 2 | Type 2 Diabetes Mellitus | - | - |
TTP889 | Phase 2 | Venous Thromboembolism | - | - |
TTP399 | Phase 2 | Diabetes Mellitus, Type 1 | - | - |
TTP273 | Phase 2 | Type 2 Diabetes Mellitus | - | - |
TTP054 | Phase 2 | Type 2 Diabetes Mellitus | - | - |
TTP435 | Phase 2 | Obesity | - | - |
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in vTv Therapeutics Inc.'s drug pipeline?→
CatalystAlert tracks 8 drug candidates in vTv Therapeutics Inc.'s (VTVT) pipeline across Phase 3, Phase 2. Its lead program is Cadisegliatin 800 mg QD (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is vTv Therapeutics Inc.'s next FDA catalyst?→
vTv Therapeutics Inc.'s (VTVT) next tracked catalyst is a Earnings expected August 11, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track VTVT biotech catalysts?→
Add VTVT to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow vTv Therapeutics Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.